SG10201709131UA - Continuous purification of therapeutic proteins - Google Patents

Continuous purification of therapeutic proteins

Info

Publication number
SG10201709131UA
SG10201709131UA SG10201709131UA SG10201709131UA SG10201709131UA SG 10201709131U A SG10201709131U A SG 10201709131UA SG 10201709131U A SG10201709131U A SG 10201709131UA SG 10201709131U A SG10201709131U A SG 10201709131UA SG 10201709131U A SG10201709131U A SG 10201709131UA
Authority
SG
Singapore
Prior art keywords
therapeutic proteins
continuous purification
purification
continuous
proteins
Prior art date
Application number
SG10201709131UA
Inventor
Konstantin Konstantinov
Rahul Godawat
Veena Warikoo
Sujit Jain
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of SG10201709131UA publication Critical patent/SG10201709131UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1807—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using counter-currents, e.g. fluidised beds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3814—Affinity chromatography of the substrate or co-factor - enzyme type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/52—Mobile; Means for transporting the apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10—Separation or concentration of fermentation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Clinical Laboratory Science (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG10201709131UA 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins SG10201709131UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361775060P 2013-03-08 2013-03-08
US201361856390P 2013-07-19 2013-07-19

Publications (1)

Publication Number Publication Date
SG10201709131UA true SG10201709131UA (en) 2017-12-28

Family

ID=50424717

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201709131UA SG10201709131UA (en) 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins
SG11201506775VA SG11201506775VA (en) 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins
SG10202011130TA SG10202011130TA (en) 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG11201506775VA SG11201506775VA (en) 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins
SG10202011130TA SG10202011130TA (en) 2013-03-08 2014-03-03 Continuous purification of therapeutic proteins

Country Status (15)

Country Link
US (5) US9650412B2 (en)
EP (1) EP2964663A2 (en)
JP (2) JP6608705B2 (en)
KR (1) KR102257356B1 (en)
CN (1) CN105377874A (en)
AU (3) AU2014226126B2 (en)
BR (1) BR112015021495A2 (en)
CA (1) CA2902854C (en)
HK (1) HK1219964A1 (en)
IL (2) IL274646B (en)
MX (2) MX2015012114A (en)
RU (2) RU2768003C2 (en)
SG (3) SG10201709131UA (en)
TW (3) TWI702226B (en)
WO (1) WO2014137903A2 (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US10689678B2 (en) 2008-11-04 2020-06-23 The Quaker Oats Company Method and composition comprising hydrolyzed starch
US10980244B2 (en) 2008-11-04 2021-04-20 The Quaker Oats Company Whole grain composition comprising hydrolyzed starch
CA2830966C (en) 2011-03-21 2016-04-19 Pepsico, Inc. Method for preparing high acid rtd whole grain beverages
US10092016B2 (en) 2011-07-12 2018-10-09 Pepsico, Inc. Method of preparing an oat-containing dairy beverage
ES2895173T3 (en) * 2012-06-29 2022-02-17 Emd Millipore Corp Methods to inactivate viruses during a protein purification process
MX367025B (en) 2013-02-22 2019-08-02 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof.
ES2717927T3 (en) 2013-02-22 2019-06-26 Genzyme Corp Cultivation procedures by perfusion of microcarriers and uses thereof
RU2768003C2 (en) 2013-03-08 2022-03-22 Джензим Корпорейшн Integrated continuous production of therapeutic protein-based medicinal agents
TW202332774A (en) 2013-10-23 2023-08-16 美商健臻公司 Recombinant glycoproteins and uses thereof
US20160298072A1 (en) * 2013-11-20 2016-10-13 Cmc Biologics A/S A bioreactor system and method for producing a biopol ymer
TWI709569B (en) 2014-01-17 2020-11-11 美商健臻公司 Sterile chromatography resin and use thereof in manufacturing processes
TWI671312B (en) 2014-01-17 2019-09-11 美商健臻公司 Sterile chromatography and manufacturing processes
ES2864721T3 (en) 2014-02-07 2021-10-14 Cmc Biologics As Arrangement and continuous process of a bioreactor for the production and capture of a biopolymer
NZ724826A (en) 2014-04-16 2022-07-29 Cmc Biologics As A high cell density fill and draw fermentation process
TWI743024B (en) 2014-06-06 2021-10-21 美商健臻公司 Perfusion culturing methods and uses thereof
TWI776235B (en) 2014-06-09 2022-09-01 美商健臻公司 Seed train processes and uses thereof
HUE060385T2 (en) 2014-10-24 2023-02-28 Genzyme Corp Integrated continuous isolation of fluid streams from sterile process vessels
WO2016106291A1 (en) * 2014-12-22 2016-06-30 Alexion Pharmaceuticals, Inc. Methods of purifying recombinant proteins
BR112017013423B1 (en) 2014-12-22 2023-04-11 Genzyme Corporation MAMMALIAN CELL CULTIVATION METHODS
WO2016156153A1 (en) * 2015-03-31 2016-10-06 Ge Healthcare Bio-Sciences Ab A liquid chromatograhy system, a device, and a method
EP3015542A1 (en) 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modular system and method for continuous, germ reduced production and/or processing of a product
EP3037513A1 (en) * 2015-05-13 2016-06-29 Bayer Technology Services GmbH Method for the continuous elution of a product from chromatography columns
EP3093335A1 (en) * 2015-05-13 2016-11-16 Bayer Technology Services GmbH Process control system for regulating and controlling a modular system for the production of biopharmaceutical and biological macromolecular products
CA3001761A1 (en) * 2015-10-26 2017-05-04 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
JP6878762B2 (en) * 2015-12-18 2021-06-02 ウシオ電機株式会社 Light irradiation device and light irradiation method
US11172695B2 (en) 2016-03-22 2021-11-16 The Quaker Oats Company Method, apparatus, and product providing hydrolyzed starch and fiber
US20170275662A1 (en) * 2016-03-22 2017-09-28 The Quaker Oats Company Method and Apparatus for Controlled Hydrolysis
KR102535013B1 (en) * 2016-04-14 2023-05-22 트리젤 엘티디. Fixed bed bioreactor with constant flow pump/tubing system
US11261416B2 (en) * 2016-04-14 2022-03-01 Trizell Ltd. Fixed-bed bioreactor with constant-flow pump / tubing system
CN109641050A (en) 2016-08-16 2019-04-16 里珍纳龙药品有限公司 Method for being quantified to the individual antibody in mixture
BR112019003013A2 (en) * 2016-08-16 2019-05-14 Genzyme Corporation methods of processing a fluid including a recombinant therapeutic protein and use thereof
CN109689853B (en) 2016-08-27 2022-08-23 三维生物科技有限公司 Bioreactor
EP3500586B1 (en) * 2016-10-17 2021-02-24 Enzene Biosciences Ltd. Continuous process for reducing heterogeneity of therapeutic protein
CN109923411B (en) 2016-10-25 2022-05-31 里珍纳龙药品有限公司 Method and system for chromatographic data analysis
BE1024230B1 (en) * 2016-11-08 2017-12-20 Univercells Sa Contained production of cells and / or cellular products
KR102492455B1 (en) * 2016-11-24 2023-01-27 알베오릭스 테크놀러지스 아게 Cell culture systems and methods
TW201829770A (en) 2017-01-10 2018-08-16 美商阿米庫斯醫療股份有限公司 Recombinant alpha-galactosidase a for treatment of fabry disease
EP3586123B1 (en) * 2017-02-21 2023-03-08 Cytiva Sweden AB Methods and systems for adapting pathlength and/or wavelength of a uv-absorbance cell in a chromatography system
EP3381529A1 (en) 2017-03-29 2018-10-03 EMD Millipore Corporation Facility for treating a biological fluid
EP3381530A1 (en) 2017-03-29 2018-10-03 EMD Millipore Corporation Facility for treating a biological fluid
WO2018183971A1 (en) * 2017-04-01 2018-10-04 Massachusetts Institute Of Technology Systems and methods for manufacturing biologically-produced products
EP3675988A2 (en) 2017-08-31 2020-07-08 Massachusetts Institute of Technology Hollow fibre membrane filtration systems and methods for manufacturing biologically-produced products
KR20200047702A (en) * 2017-09-15 2020-05-07 브리스톨-마이어스 스큅 컴퍼니 Online biomass capacitance monitoring during large-scale production of polypeptides of interest
WO2019060837A1 (en) * 2017-09-25 2019-03-28 Enzyvant Farber Gmbh Recombinant human acid ceramidase production process
US11609120B2 (en) 2017-10-06 2023-03-21 Lonza Ltd Automated control of cell culture using Raman spectroscopy
CA3075679A1 (en) * 2017-10-16 2019-04-25 Regeneron Pharmaceuticals, Inc. Perfusion bioreactor and related methods of use
CN108101981B (en) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 A kind of production technology of intravenous immunoglobulin
CN112703010A (en) * 2018-02-02 2021-04-23 恩真万特诊疗公司 Method for treating Fabry disease
KR20200125978A (en) 2018-03-02 2020-11-05 젠자임 코포레이션 Multivariate spectrum analysis and monitoring of biological manufacturing
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
CN111918873A (en) * 2018-03-27 2020-11-10 百时美施贵宝公司 Real-time monitoring of titre using UV signals
WO2019190752A1 (en) * 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
TW202005694A (en) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 Systems and methods for preparing a polypeptide from a mixture
JP7063759B2 (en) * 2018-07-25 2022-05-09 株式会社日立プラントサービス Purifier
BR112021003420A2 (en) 2018-08-31 2021-05-18 Genzyme Corporation sterile chromatographic resin and its use in manufacturing processes
CN111184636A (en) * 2018-11-14 2020-05-22 正大天晴药业集团南京顺欣制药有限公司 Preparation of pharmaceutical composition containing recombinant protein
JP7365419B2 (en) * 2019-01-25 2023-10-19 エンゼン・バイオサイエンシズ・リミテッド Automated integrated continuous systems and bioprocesses for producing therapeutic proteins
EP3924458A1 (en) * 2019-02-15 2021-12-22 Just-Evotec Biologics, Inc. Automated biomanufacturing systems, facilities, and processes
US20220251498A1 (en) * 2019-02-15 2022-08-11 Just-Evotec Biologics, Inc. Facilities and processes to produce biotherapeutics
JP2022527517A (en) * 2019-04-01 2022-06-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Production of integrated and continuous recombinant proteins
MX2021012078A (en) * 2019-04-03 2022-01-04 Genzyme Corp Continuous production of recombinant proteins.
GB201908612D0 (en) * 2019-06-17 2019-07-31 Ge Healthcare Bio Sciences Ab A method for separating biomolecules
CN110348090B (en) * 2019-06-28 2021-05-04 浙江大学 Method for realizing multi-column continuous flow chromatography design and analysis based on artificial neural network
CN110348089B (en) * 2019-06-28 2021-05-04 浙江大学 Method for realizing multi-column continuous flow chromatography design and analysis based on chromatography model
FR3099066B1 (en) * 2019-07-26 2021-08-13 Novasep Process Purification process of a target substance with viral inactivation
GB201911686D0 (en) * 2019-08-15 2019-10-02 Fujifilm Diosynth Biotechnologies Uk Ltd Process for purifying target substances
CN114729916A (en) * 2019-09-23 2022-07-08 建新公司 Product quality attribute measurement
CA3155216A1 (en) * 2019-10-22 2021-04-29 Robert Snow In-line product monitoring in integrated continuous bio-manufacturing
GB202003336D0 (en) * 2020-03-06 2020-04-22 National Institute For Bioprocesisng Res And Training A system for producing a biopharmaceutical product
KR102370142B1 (en) * 2020-03-23 2022-03-04 프레스티지바이오로직스 주식회사 Hybrid System of Culture and Purification Process for the Production of Antibody Pharmaceuticals
EP4026892A1 (en) 2021-01-12 2022-07-13 Sartorius Stedim Biotech GmbH Device assembly and method for controlling an integrated continuous pharmaceutical or biopharmaceutical manufacturing process
GB202101775D0 (en) * 2021-02-09 2021-03-24 Cytiva Sweden Ab Method in bioprocess purification system
CA3209216A1 (en) * 2021-03-10 2022-09-15 Amgen Inc. Methods for purification of recombinant proteins
GB202109015D0 (en) * 2021-06-23 2021-08-04 Puridify Ltd A method for purifying a feed in a chromatography system
WO2023043718A1 (en) * 2021-09-14 2023-03-23 Sanofi Chromatography system
WO2023129541A2 (en) * 2021-12-28 2023-07-06 Mott Corporation Selectable media filter and sparger assemblies and related methods of fabrication and use
TW202342522A (en) 2022-03-07 2023-11-01 日商武田藥品工業股份有限公司 Affinity chromatographic production of clinical human igg products
WO2023191009A1 (en) * 2022-03-30 2023-10-05 富士フイルム株式会社 Production method for active ingredient of biological medicine, production system for active ingredient of biological medicine, and active ingredient of biological medicine
WO2023191008A1 (en) * 2022-03-30 2023-10-05 富士フイルム株式会社 Method for manufacturing biopharmaceutical drug substance, system for manufacturing biopharmaceutical drug substance, and biopharmaceutical drug substance
WO2023247798A1 (en) 2022-06-24 2023-12-28 Bilfinger Life Science Gmbh Modular device and method for continuously producing biotechnological products
DE102022208467A1 (en) 2022-06-24 2024-01-04 Bilfinger Life Science Gmbh Modular device and method for the continuous production of biotechnological products
KR20240039642A (en) * 2022-09-19 2024-03-27 주식회사 녹십자 Novel Process for Purifying Heparan-N-Sulfatase

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401108A (en) 1980-02-13 1983-08-30 Thomas Jefferson University Radioactive material loading, calibration and injection systems
JPS6075530A (en) 1983-09-30 1985-04-27 Asahi Chem Ind Co Ltd Novel method for separating and purifying metallic element
US4559175A (en) 1984-04-19 1985-12-17 The United States Of America As Represented By The Secretary Of The Air Force Halo-substituted diphospha-s-triazines and their derivatives
US4885250A (en) 1987-03-02 1989-12-05 E. I. Du Pont De Nemours And Company Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports
US5612016A (en) 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
WO1991002049A1 (en) 1989-08-04 1991-02-21 Peter Grandics An integrated cell culture-protein purification system for the automated production and purification of cell culture products
US5244816A (en) 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
AU1742092A (en) 1991-04-05 1992-11-02 Brigham Young University Support bonded polyalkylene-polyamine-poly(carboxylic acid) and extraction of metal ions therewith
RU2034853C1 (en) 1992-07-14 1995-05-10 Научно-исследовательский институт строительных материалов при Томской государственной инженерно-строительной академии Method of preparing of polymeric sorbent for chromatography
JP2871435B2 (en) 1993-04-22 1999-03-17 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Method for producing a hydrophilic polymer coated perfluorocarbon polymer based matrix
US5478924A (en) 1994-02-16 1995-12-26 Cramer; Steven M. Displacement chromatography of proteins using low molecular weight displacers
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5423982A (en) 1994-05-31 1995-06-13 Biosepra Inc. Liquid chromatography column adapted for in situ chemical sterilization
US5610285A (en) 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US6359114B1 (en) 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
AR005035A1 (en) 1995-12-11 1999-04-07 Merck Patent Ges Mit Beschränkter Haftung PROCEDURE TO PREPARE RECOMBINANT PROTEINS IN E. COLI, BY FERMENTATION WITH GREAT CONCENTRATION OF CELLS.
PT950067E (en) 1996-11-27 2007-12-06 Genentech Inc Affinity purification of polypeptide on protein a matrix
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US6265542B1 (en) 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
US6489447B1 (en) 1998-05-06 2002-12-03 Genentech, Inc. Protein purification
DE19858892A1 (en) 1998-12-19 2000-06-21 Merck Patent Gmbh Continuous chromatographic separation of matter by molecular sizes useful e.g. for separation of isomers, uses a simulated moving bed for size exclusion chromatography
GB0028879D0 (en) 2000-11-27 2001-01-10 Prometic Biosciences Ltd Adsorbents and their use
HUP0303246A2 (en) 2001-02-23 2003-12-29 Immunex Corporation Increased recovery of active proteins
ITBO20010426A1 (en) * 2001-07-06 2003-01-06 Alfa Wassermann Spa PHARMACOLOGICALLY ACTIVE PROTEIN PURIFICATION PROCESS BY CATIONIC EXCHANGE CHROMATOGRAPHY
AU2002343100A1 (en) 2001-11-27 2003-06-10 Prometic Biosciences Ltd. The use of metal-chelating adsorbents
US6660172B2 (en) 2002-01-31 2003-12-09 Koslow Technologies Corporation Precoat filtration media and methods of making and using
US6870034B2 (en) 2002-02-05 2005-03-22 Genentech, Inc. Protein purification
JP4319979B2 (en) 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド Non-affinity purification of proteins
US6902909B2 (en) 2002-07-09 2005-06-07 Synthecon, Inc. Methods for efficient production of mammalian recombinant proteins
LT1543038T (en) 2002-09-11 2017-07-10 Genentech, Inc. Protein purification
CA2498725C (en) 2002-09-13 2014-07-08 Biogen Idec Inc. Method of purifying polypeptides by simulated moving bed chromatography
US7157276B2 (en) 2003-06-20 2007-01-02 Biogen Idec Inc. Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
WO2005082937A2 (en) 2004-02-27 2005-09-09 Octapharma Ag A method of providing a purified, virus safe antibody preparation
CN101001945B (en) 2004-06-04 2012-02-08 艾克塞勒雷克斯公司 Disposable bioreactor systems and methods
WO2006026248A1 (en) 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
ES2634323T3 (en) 2004-09-30 2017-09-27 Bayer Healthcare Llc Devices and procedures for the continuous integrated manufacture of biological molecules
PL1827691T3 (en) 2004-10-21 2017-07-31 Ge Healthcare Bioprocess R&D Ab Chromatography matrix
JP5553963B2 (en) 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド Methods for refolding recombinant antibodies
JP2008525032A (en) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド Methods for expressing and purifying recombinant human growth hormone
EP1855729B1 (en) 2005-03-07 2013-10-30 GE Healthcare Bio-Sciences AB Method of heat sterilization of a chromatography column
US8043833B2 (en) 2005-10-31 2011-10-25 Novo Nordisk A/S Expression of soluble therapeutic proteins
EP1963367A4 (en) 2005-12-06 2009-05-13 Amgen Inc Polishing steps used in multi-step protein purification processes
US7673757B2 (en) 2006-02-17 2010-03-09 Millipore Corporation Adsorbent filter media for removal of biological contaminants in process liquids
MX2008010604A (en) 2006-02-17 2009-03-05 Novartis Ag Purification of bacterial antigens.
US8117924B2 (en) 2006-04-21 2012-02-21 Bayer Healthcare Llc Apparatus, system, and method for in-situ measurements
WO2008036899A2 (en) 2006-09-22 2008-03-27 Amgen Inc. Methods for removing viral contaminants during protein purification
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US9597610B2 (en) 2007-03-09 2017-03-21 Ge Healthcare Bioprocess R&D Ab Packing system and method for chromatography columns
GB0704603D0 (en) 2007-03-09 2007-04-18 Ge Healthcare Bio Sciences Ab Packing system and method for chromatography columns
DK2155347T3 (en) 2007-04-17 2013-10-21 Xendo Holding B V Method and apparatus for continuous membrane adsorption
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
PL2840090T3 (en) * 2007-10-30 2018-07-31 Genentech, Inc. Antibody purification by cation exchange chromatography
TWI468516B (en) 2007-12-27 2015-01-11 Otsuka Pharma Co Ltd Enzyme associated with equol synthesis
US20110086366A1 (en) * 2008-02-22 2011-04-14 Genmab A/S Methods for assessing the risk of adverse events upon treatment with igg4 antibodies
KR101700722B1 (en) * 2008-06-24 2017-01-31 옥타파마 아게 A process of purifying coagulation factor VIII
US9441028B2 (en) * 2008-12-08 2016-09-13 Novo Nordisk A/S Counter current purification of polypeptides
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
US8728479B2 (en) 2009-03-31 2014-05-20 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
US8580554B2 (en) 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture
EP2493514B1 (en) 2009-10-29 2018-08-22 Ascendis Pharma A/S Sterilization of biodegradable hydrogels
GB0922426D0 (en) 2009-12-22 2010-02-03 Ge Healthcare Bio Sciences Ab Containers for chromatography media
WO2011078772A1 (en) 2009-12-22 2011-06-30 Ge Healthcare Bio-Sciences Ab Method for dry packing chromatography columns
US9943781B2 (en) 2010-06-03 2018-04-17 Ge Healthcare Bioprocess R&D Ab Parallel assembly of chromatography column modules
EP3578522A1 (en) 2010-12-06 2019-12-11 Pall Corporation Continuous processing methods for biological products
CN102321316B (en) 2011-08-25 2013-04-24 上海恒方大高分子材料科技有限公司 Medical polyvinyl chloride (PVC) material for gamma-ray irradiation disinfection and preparation method thereof
EP2656892A1 (en) 2012-04-23 2013-10-30 Merck Patent GmbH Chromatography method
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
ES2895173T3 (en) 2012-06-29 2022-02-17 Emd Millipore Corp Methods to inactivate viruses during a protein purification process
CN105777862A (en) * 2012-10-24 2016-07-20 建新公司 Elution of biomolecules from multi-modal resins using MES and MOPS as mobile phase modifiers
RU2768003C2 (en) 2013-03-08 2022-03-22 Джензим Корпорейшн Integrated continuous production of therapeutic protein-based medicinal agents
TWI671312B (en) 2014-01-17 2019-09-11 美商健臻公司 Sterile chromatography and manufacturing processes
EP3094391A4 (en) 2014-01-17 2017-09-20 Repligen Corporation Sterilizing chromatography columns
TWI709569B (en) 2014-01-17 2020-11-11 美商健臻公司 Sterile chromatography resin and use thereof in manufacturing processes

Also Published As

Publication number Publication date
RU2768003C2 (en) 2022-03-22
MX2015012114A (en) 2016-01-12
AU2014226126A1 (en) 2015-10-01
MX2020001823A (en) 2020-07-13
RU2015142657A (en) 2017-04-13
JP2020033364A (en) 2020-03-05
EP2964663A2 (en) 2016-01-13
IL240792A0 (en) 2015-10-29
US20170218012A1 (en) 2017-08-03
TWI702226B (en) 2020-08-21
SG11201506775VA (en) 2015-09-29
US20140255994A1 (en) 2014-09-11
RU2018122100A3 (en) 2021-08-06
KR20150125714A (en) 2015-11-09
RU2018122100A (en) 2019-03-12
US9650412B2 (en) 2017-05-16
CA2902854C (en) 2024-01-23
CN105377874A (en) 2016-03-02
KR102257356B1 (en) 2021-05-31
AU2014226126B2 (en) 2019-02-14
US9650413B2 (en) 2017-05-16
TW201920230A (en) 2019-06-01
AU2021200474A1 (en) 2021-02-25
AU2019203128A1 (en) 2019-05-30
SG10202011130TA (en) 2020-12-30
AU2021200474B2 (en) 2024-05-23
TW202043252A (en) 2020-12-01
US10711034B2 (en) 2020-07-14
WO2014137903A3 (en) 2014-10-30
IL274646A (en) 2020-06-30
US20150232505A1 (en) 2015-08-20
JP2016510981A (en) 2016-04-14
WO2014137903A2 (en) 2014-09-12
JP6608705B2 (en) 2019-11-20
US20200317726A1 (en) 2020-10-08
RU2662929C2 (en) 2018-07-31
AU2019203128B2 (en) 2020-10-29
TW201518315A (en) 2015-05-16
HK1219964A1 (en) 2017-04-21
US20150183821A1 (en) 2015-07-02
BR112015021495A2 (en) 2017-07-18
US9657056B2 (en) 2017-05-23
CA2902854A1 (en) 2014-09-12
TWI659965B (en) 2019-05-21
IL274646B (en) 2022-09-01
IL240792B (en) 2020-05-31

Similar Documents

Publication Publication Date Title
HK1219964A1 (en) Continuous purification of therapeutic proteins
IL287516A (en) Therapeutic uses of empagliflozin
HRP20190101T1 (en) Therapeutic uses of empagliflozin
HK1213818A1 (en) Therapeutic uses of empagliflozin
HK1222552A1 (en) Sobetirome in the treatment of myelination diseases
EP2997036A4 (en) Purification of recombinantly produced polypeptides
SG11201603028SA (en) Purification of proteins
EP2976352A4 (en) Purification of triple helical proteins
RS58097B1 (en) Therapeutic uses of empagliflozin
SG11201505198WA (en) Protein purification methods
HK1216429A1 (en) Methods for purification of rylsulfatase
EP2957306A4 (en) Blood purification column
SG11201505204VA (en) Protein purification process
IL268868B (en) Novel method of protein purification
EP3043813A4 (en) Purification of chimeric fviii molecules
IL241418A0 (en) Title improved methods of use for recombinant human secretoglobins
HK1220127A1 (en) Treatment of autoimmune diseases
IL241248A0 (en) Enhanced expression of picornavirus proteins
HK1214964A1 (en) Methods to produce particles comprising therapeutic proteins